76 - Strong Like Her: Women and HIV

Thursday, October 17, 2024

1:45 PM – 3:00 PM US PT

Location: 408 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Aadia Rana, MD (she/her/hers)

Professor of Medicine
University of Alabama-Birmingham Heersink School of Medicine
Birmingham, AL, United States
Seble Kassaye, MD, MS

Associate Professor of Medicine
Georgetown University Medical Center, Washington, DC
Washington, DC, United States

Faculty(s)

Whitney Irie, PhD (she/her/hers)

Assistant Professor
Boston College, School of Social Work
Elizabeth King, MD, MHSc (she/her/hers)

Assistant Professor
Simon Fraser University
Burnaby, BC, Canada
Elizabeth Bukusi, MBChb, MMed(Obgyn), MPH, PhD, PFD, MBE (she/her/hers)

Senior principal Clinical Research Scientist
Kenya Medical Research Institute
Nairobi, Kenya

Disclosure(s):

Seble G. Kassaye, MD, MS: Vindico CME: Honoraria (Terminated, March 31, 2024)

Whitney Irie, PhD: ViiV Healthcare/GSK: Grant/Research Support (Ongoing)

Elizabeth M. King, MD, MHSc: Merck and Company, Inc.: Advisor/Consultant (Terminated, October 30, 2022)

Elizabeth Anne Bukusi, MBChb, MMed(Obgyn), MPH, PhD, PFD, MBE: AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Advisor/Consultant (Terminated); Gilead Biosciences: Advisor/Consultant (Terminated); LOREAL: Advisor/Consultant (Ongoing); MSD: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain advances and barriers to reducing the impact of hiv on women and children globally;
describe clinical considerations for menopause in people with hiv;
describe hiv prevention options for cisgender women.

Presentations:

1:45 PM – 2:10 PM US PT

HIV Prevention for Black Cis-Gender Women in the US
Speaker: Whitney Irie, PhD (she/her/hers) – Boston College, School of Social Work
2:10 PM – 2:35 PM US PT

Menopause and HIV Interactions
Speaker: Elizabeth M. King, MD, MHSc (she/her/hers) – Simon Fraser University
2:35 PM – 3:00 PM US PT

Global HIV in Women and Children: Progress and Challenges
Speaker: Elizabeth Anne Bukusi, MBChb, MMed(Obgyn), MPH, PhD, PFD, MBE (she/her/hers) – Kenya Medical Research Institute